Cargando…

Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019

Detalles Bibliográficos
Autores principales: Ogawa, Yoshihiko, Nagata, Toshihiko, Akiyama, Taisuke, Nishida, Koji, Kumasawa, Junji, Kohno, Michihiko, Kohata, Hisakazu, Gohma, Iwao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418284/
https://www.ncbi.nlm.nih.gov/pubmed/32780355
http://dx.doi.org/10.1007/s11239-020-02248-8
_version_ 1783569662581145600
author Ogawa, Yoshihiko
Nagata, Toshihiko
Akiyama, Taisuke
Nishida, Koji
Kumasawa, Junji
Kohno, Michihiko
Kohata, Hisakazu
Gohma, Iwao
author_facet Ogawa, Yoshihiko
Nagata, Toshihiko
Akiyama, Taisuke
Nishida, Koji
Kumasawa, Junji
Kohno, Michihiko
Kohata, Hisakazu
Gohma, Iwao
author_sort Ogawa, Yoshihiko
collection PubMed
description
format Online
Article
Text
id pubmed-7418284
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-74182842020-08-11 Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019 Ogawa, Yoshihiko Nagata, Toshihiko Akiyama, Taisuke Nishida, Koji Kumasawa, Junji Kohno, Michihiko Kohata, Hisakazu Gohma, Iwao J Thromb Thrombolysis Letter to the Editor Springer US 2020-08-11 2020 /pmc/articles/PMC7418284/ /pubmed/32780355 http://dx.doi.org/10.1007/s11239-020-02248-8 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Ogawa, Yoshihiko
Nagata, Toshihiko
Akiyama, Taisuke
Nishida, Koji
Kumasawa, Junji
Kohno, Michihiko
Kohata, Hisakazu
Gohma, Iwao
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
title Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
title_full Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
title_fullStr Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
title_full_unstemmed Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
title_short Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
title_sort argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418284/
https://www.ncbi.nlm.nih.gov/pubmed/32780355
http://dx.doi.org/10.1007/s11239-020-02248-8
work_keys_str_mv AT ogawayoshihiko argatrobantherapyforheparininducedthrombocytopeniainapatientwithcoronavirusdisease2019
AT nagatatoshihiko argatrobantherapyforheparininducedthrombocytopeniainapatientwithcoronavirusdisease2019
AT akiyamataisuke argatrobantherapyforheparininducedthrombocytopeniainapatientwithcoronavirusdisease2019
AT nishidakoji argatrobantherapyforheparininducedthrombocytopeniainapatientwithcoronavirusdisease2019
AT kumasawajunji argatrobantherapyforheparininducedthrombocytopeniainapatientwithcoronavirusdisease2019
AT kohnomichihiko argatrobantherapyforheparininducedthrombocytopeniainapatientwithcoronavirusdisease2019
AT kohatahisakazu argatrobantherapyforheparininducedthrombocytopeniainapatientwithcoronavirusdisease2019
AT gohmaiwao argatrobantherapyforheparininducedthrombocytopeniainapatientwithcoronavirusdisease2019